Search Results 981-990 of 18632 for Relapse
... relapse after achieving a partial response to their most recent standard treatment regimen) who have a complete or partial remission of proteinuria in ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...
If your body doesn't respond to the initial treatment of multiple myeloma or if you have a relapse, there may be other options. Here are some follow-up ...
A bone marrow transplant may be an option for some relapsed or refractory non-Hodgkin lymphomas. Chemotherapy or radiation therapy is typically done before the ...
Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or ...
Some non-Hodgkin lymphomas behave like chronic conditions because they may relapse over many years. The cause of Hodgkin lymphoma and non-Hodgkin lymphoma ...
It is ... DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas Rochester, MN. The ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.